We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Zonisamide in Parkinson's Disease: An Evidence-Based Review of its Impact on Clinical Outcomes.
- Authors
Skodda, Sabine
- Abstract
Zonisamide is a benzoisoxazole derivate with a multimodal mechanism of action that is widely available as antieplieptic drug. Serpendipitously discovered to exert beneficial effects on motor symptoms of Parkinson's disease (PD), zonisamide has been approved exclusively in Japan for the adjunctive treatment of Parkinsonian symptoms after the positive results of three controlled clinical trials. The current review gives a resumé of the main findings of clinical trials and casuistic reports of the effects of zonisamide in PD with special emphasis on possible mechanisms of action and adverse effects. Summarized, at that time, the use of zonisamide in PD is still investigational; further studies are warranted to confirm the preliminary promising findings and to better define effects, indications and tolerability of zonisamide in PD.
- Subjects
ANTHRANIL; DRUGS; PARKINSON'S disease treatment; DRUG therapy for Parkinson's disease; CLINICAL trials
- Publication
Clinical Medicine Reviews in Therapeutics, 2012, Vol 4, p89
- ISSN
1179-2558
- Publication type
Article
- DOI
10.4137/CMRT.S3429